ArticleJournal of experimental & clinical cancer research : CR2017

Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer.

Bernhard Englinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.